Pazoci 400 mg (Pazopanib) is a prescription Tyrosine Kinase Inhibitor (TKI) manufactured by Cipla, used to treat advanced kidney cancer (renal cell carcinoma) and certain types of soft-tissue sarcoma. It works by disrupting tumor blood vessel formation to halt cancer growth.
liketo.usa,uk,china,southkorea,russia,japan,singapore
Strength 400 mg
Dose/Strength 400 mg
Tablets per Pack 30 Tablets
Usage Cancer Care, Sarcoma, Renal Cancer
Pack Type Bottle
Form Tablet
Manufactured By Cipla
Country of Origin Made in India
Brand Pazoci
Packaging Size 30 Tablets
Packaging Type Bottle
Composition Pazopanib Hydrochloride Tablets
Minimum order quantity: 50 Bottle
We offer reliable delivery across India and international markets. Domestic orders are typically delivered within 5-7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity.